search
Back to results

Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control (ADL)

Primary Purpose

Hyperlipidemia, Hyperglycemia, Type 2 Diabetes

Status
Recruiting
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
Adlay with white rice
white rice
Sponsored by
National Taiwan University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hyperlipidemia focused on measuring Adlay, Hyperlipidemia, Hyperglycemia

Eligibility Criteria

20 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Hyperlipidemia: Levels of LDL-choleterol equal or greater than 130 mg/dL, or triglyceride equal or greater than 150 mg/dL Hyperglycemia: fasting glucose equal or greater than 100 mg/dL Exclusion Criteria: Secondary hyperglycemia Secondary hyperlipidemia

Sites / Locations

  • National Taiwan University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Adlay with white rice

White rice

Arm Description

Group A eat cooked adlay with white rice to replace their carbohydrates: a box of 200 grams of adlay rice per day

Group B ate a box of 200 grams of cooked white rice per day

Outcomes

Primary Outcome Measures

Fasting blood glucose
glucose-lowering effects
Cholesterol
Lipids
HDL-cholesterol
Lipids
LDL-cholesterol
Lipids
Triglycerides
Lipids
Glycosylated hemoglobin (HbA1C)
Hemoglobin A1C is a form of hemoglobin (Hb) that is chemically linked to sugar

Secondary Outcome Measures

Blood pressure
physiological biomarkers
Body composition
The percentages of fat, bone and muscle in human bodies by bioelectric impedance technology
hs-CRP (high sensitivity C-reactive protein)
Inflammation
Free T4 and TSH (Thyroid Stimulating Hormone)
Thyroid function tests
Insulin
A peptide hormone produced by beta cells of the pancreatic islets
Gastrin, Cholecystokinine, and Glucagon-like peptide 1
Intestin Hormones
Small-dense LDL-cholesterol
LDL subpopulation particles

Full Information

First Posted
July 24, 2023
Last Updated
August 17, 2023
Sponsor
National Taiwan University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05990595
Brief Title
Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control
Acronym
ADL
Official Title
Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control (ADL)
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 7, 2023 (Actual)
Primary Completion Date
September 28, 2023 (Anticipated)
Study Completion Date
November 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
National Taiwan University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia. Through two weeks of cooked adlay-rice and white rice by a randomized cross-over design to evaluate the lipid- and glucose-lowering effects of adlay on patient with hyperlipidemia and/or hyperglycemia.
Detailed Description
Evaluation of health effects of domestic adlay on lowering cholesterol and blood sugar Hyperlipidemia and diabetes are major risk factors for cardiovascular disease. Clinical experiments have preliminarily proved that phytosterols can help lower blood lipids, and adlay is one of the domestic economic crops that has animal experimental evidence or theoretical potential to be beneficial to blood lipids and blood sugar control, which needs to be further explored and verified. This study explores the efficacy of domestic adlay in improving blood sugar and lipids metabolism, cardiovascular function, and weight control in people with high blood pressure, hyperlipidemia, and hyperglycemia. We plan to recruit 60 patients with hyperglycemia or hyperlipidemia. aged between 20 and 80 years old, from National Taiwan University Hospital. This study is focused on high blood cholesterol, triglycerides, and hyperglycemia groups, thus participants must have higher cholesterol, triglycerides, or higher fasting blood glucose concentration even under currently stable treatment for at least 6 months. Lipid-lowering and hypoglycemic medication cannot be changed during this trial. The clinical trial adopts a randomized cross-over trial, the experimental group to eat white rice with adlay and the control group to eat white rice. Participants in the project were randomly divided into two groups, group A and B, with 30 people in each group. Group A eat adlay to replace their carbohydrates: a box of 200 grams of rice (the amount of rice in dry weight is 36 grams of adlay and 54 grams of white rice) per day; Group B ate a box of 200 grams of white rice (the amount of rice was 87 grams based on dry weight) per day. After the first run of study, all participants resume to the original regular diet for two weeks, and then switch groups for crossover trial after the two-week washout period. In the experiment, during the crossover experiment, group A and group B replaced the experimental ingredients, that is, the original white rice group was replaced by adlay with white rice, and the original adlay and white rice group was replaced with white rice for a period of two weeks. To ensure that the test material is homogeneous and uniform, the white rice with adlay is made from the "cooked rice with adlay" produced by Nanqiao Group, HUACIANG INDUSTRY CO., LTD. The adlay cooked rice contains 40% adlay and Taichung No. 194 white rice 60%, and the control group used Taichung No. 194 white rice. Every participant have to receive blood and urine sampling for biochemical measurement in each stage, 1. Baseline, 2. Two weeks after first stage: adlay with white rice or white rice, 3. Washed period stage for 2 weeks, 4. Two weeks after crossover stage. The main results analysis includes fasting blood sugar,glycosylated hemoglobin, glycosylated hemoglobin, triglycerides, total cholesterol, high-density cholesterol, and low-density cholesterol. Secondary outcome analysis includes blood pressure, body composition analysis, inflammation index, thyroid function, levels of intestinal hormones (cholecystokinin, gastrin) and glucagon-like peptide-1, and other emerging blood lipid indicators, such as small-dense LDL-C. The above measurements will be performed every 2 weeks for each stage. Pittsburgh Sleep Quality Index and Center for Epidemiological Studies Depression Scale (CES-D) will also be assessed every 2 weeks for each stage. Keywords: hyperlipidemia, hyperglycemia, diabetes mellitus, randomized crossover trial

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hyperlipidemia, Hyperglycemia, Type 2 Diabetes
Keywords
Adlay, Hyperlipidemia, Hyperglycemia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
The clinical trial adopts a randomized cross-over trial, the experimental group to eat white rice with adlay and the control group to eat white rice. Participants in the project were randomly divided into two groups, group A and B, with 30 people in each group. Group A eat 200 gm cooked adlay with white rice to replace their carbohydrates; Group B ate a box of 200 grams of white rice per day. After the first run of study, all participants resume to the original regular diet for two weeks, and then switch groups for crossover trial after the two-week washout period. In the experiment, during the crossover experiment, group A and group B replaced the experimental ingredients, that is, the original white rice group was replaced by adlay with white rice, and the original adlay and white rice group was replaced with white rice for a period of two weeks.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Adlay with white rice
Arm Type
Experimental
Arm Description
Group A eat cooked adlay with white rice to replace their carbohydrates: a box of 200 grams of adlay rice per day
Arm Title
White rice
Arm Type
Placebo Comparator
Arm Description
Group B ate a box of 200 grams of cooked white rice per day
Intervention Type
Dietary Supplement
Intervention Name(s)
Adlay with white rice
Intervention Description
We will investigate the lipid- and glucose-lowering effects of Adlay rice in comparison to white rice through a randomized cross-over trial.
Intervention Type
Dietary Supplement
Intervention Name(s)
white rice
Intervention Description
white rice
Primary Outcome Measure Information:
Title
Fasting blood glucose
Description
glucose-lowering effects
Time Frame
2 weeks for each stage
Title
Cholesterol
Description
Lipids
Time Frame
2 weeks for each stage
Title
HDL-cholesterol
Description
Lipids
Time Frame
2 weeks for each stage
Title
LDL-cholesterol
Description
Lipids
Time Frame
2 weeks for each stage
Title
Triglycerides
Description
Lipids
Time Frame
2 weeks for each stage
Title
Glycosylated hemoglobin (HbA1C)
Description
Hemoglobin A1C is a form of hemoglobin (Hb) that is chemically linked to sugar
Time Frame
2 weeks for each stage
Secondary Outcome Measure Information:
Title
Blood pressure
Description
physiological biomarkers
Time Frame
2 weeks for each stage
Title
Body composition
Description
The percentages of fat, bone and muscle in human bodies by bioelectric impedance technology
Time Frame
2 weeks for each stage
Title
hs-CRP (high sensitivity C-reactive protein)
Description
Inflammation
Time Frame
2 weeks for each stage
Title
Free T4 and TSH (Thyroid Stimulating Hormone)
Description
Thyroid function tests
Time Frame
2 weeks for each stage
Title
Insulin
Description
A peptide hormone produced by beta cells of the pancreatic islets
Time Frame
2 weeks for each stage
Title
Gastrin, Cholecystokinine, and Glucagon-like peptide 1
Description
Intestin Hormones
Time Frame
2 weeks for each stage
Title
Small-dense LDL-cholesterol
Description
LDL subpopulation particles
Time Frame
2 weeks for each stage
Other Pre-specified Outcome Measures:
Title
Pittsburgh Sleep Quality Index
Description
Sleep quality assessment
Time Frame
2 weeks for each stage
Title
Center for Epidemiologic Studies Depression Scale (CES-D), NIMH
Description
Depression scale assessment
Time Frame
2 weeks for each stage

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Hyperlipidemia: Levels of LDL-choleterol equal or greater than 130 mg/dL, or triglyceride equal or greater than 150 mg/dL Hyperglycemia: fasting glucose equal or greater than 100 mg/dL Exclusion Criteria: Secondary hyperglycemia Secondary hyperlipidemia
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ta-Chen Su, MD, PhD
Phone
+886-972651062
Email
tachensu@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Cheng-Yu Chiang, MSc
Phone
+886-965813735
Email
oldchiang@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ta-Chen Su, MD, PhD
Organizational Affiliation
National Taiwan University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
National Taiwan University Hospital
City
Taipei
ZIP/Postal Code
10002
Country
Taiwan
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ta-Chen Su, MD, PhD
Phone
+886-972651062
Email
tachensu@gmail.com
First Name & Middle Initial & Last Name & Degree
Cheng-Yu Chiang, MSc
Phone
+886-965813735
Email
oldchiang@gmail.com
First Name & Middle Initial & Last Name & Degree
Ta-Chen Su, MD, PhD

12. IPD Sharing Statement

Learn more about this trial

Evaluation of Health Effects of Adlay on Hyperlipidemia and Hyperglycemia Control

We'll reach out to this number within 24 hrs